Location of Repository

Pneumococcal interactions with mucin

By Vanessa Sofia Agostinho Terra


The nasopharynx is covered by mucin. Mucin is a glycoprotein and the carbohydrate moieties are potential fermentable substrates for Streptococcus pneumoniae. Previous in vitro studies showed that S. pneumoniae can grow on mucin. This study was undertaken to investigate how S. pneumoniae degrades the mucin carbohydrates to mono and disaccharides for subsequent fermentation. In silico search of pneumococcal genome identified fourteen putative glycosidases. Pneumococcal mutants of each were made and tested for growth in defined medium with mucin as the only source of carbon. Of these, two genes SPD0065 and SPD0247 were chosen for further study. Consequently two novel glycosidases were described, β-galactosidase (BgaC), encoded by gene SPD0065 and a 6-phospho-β-glucosidase (BglA) encoded by gene SPD0247. The knocked-out mutants SPD0065M and SPD0247M could not grow in Sicard’s defined medium supplemented with mucin and exhibited decreased enzymatic activity when compared to the wild type D39. Since gene SPD0562 had been previously identified as encoding a β-galactosidase (BgaA), the relative contribution of BgaA and BgaC to total β-galactosidase activity was investigated by introducing mutations in these genes individually and together. Mutation in the individual genes resulted in significant decrease in the enzymatic activity but the double mutation did not totally abolished activity. BgaC had specificity for galactose (β1,3)-N-acetylgalactosamine. Furthermore, BgaC released galactose from desialylated fetuin. The expression of SPD0065 and SPD0247 in S. pneumoniae grown in mucin containing medium or harvested from tissues from infected animals was significantly up-regulated compared to growth in glucose containing medium. When the mutants were tested in vivo, it was noted that SPD0065M had attenuated growth in the nasopharynx and SPD0247M in the lungs. In this study was demonstrated that BgaC has a role in the sequential deglycosylation of host glycoproteins and that BglA is involved in the further degradation of mucin-derived sugars

Publisher: University of Leicester
Year: 2011
OAI identifier: oai:lra.le.ac.uk:2381/9389

Suggested articles



  1. (1997). A capillary electrophoretic study on the specificity of beta-galactosidases from Aspergillus oryzae, Escherichia coli, Streptococcus pneumoniae, and Canavalia ensiformis (jack bean). Analytical Biochemistry.
  2. (1991). A classification of glycosyl hydrolases based on amino acid sequence similarities.
  3. (1987). A fetuinrelated glycoprotein (alpha 2HS) in human embryonic and fetal development.
  4. (2005). A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiology and Infection.
  5. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.
  6. (1994). A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infection and Immunity.
  7. (1964). A New Synthetic Medium for Diplococcus Pneumoniae, and its use for the study of reciprocal transformations at the Ami A Locus.
  8. (1995). A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.
  9. (1996). A purified mariner transposase is sufficient to mediate transposition in vitro.
  10. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
  11. (1993). ABC transporters: bacterial exporters.
  12. (1992). ABC transporters: from microorganisms to man.
  13. (2006). Active Bacterial Core Surveillance Team,
  14. (1986). Acute respiratory infections are the leading cause of death in children in developing countries.
  15. (2000). Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infection and Immunity.
  16. (1997). Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertility and Sterility.
  17. (2001). alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface.
  18. (1998). Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
  19. (2002). Anaerobic sugar catabolism in Lactococcus lactis: genetic regulation and enzyme control over pathway flux.
  20. (2001). Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T
  21. (2002). Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors.
  22. (2010). and Hasan Yesilkaya ‘Characterization of Novel β-Galactosidase Activity That Contributes to Glycoprotein Degradation and Virulence
  23. (2004). Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).
  24. (2003). Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children. The Pediatric Infectious Disease
  25. (2006). Antimicrobial proteins and polypeptides in pulmonary innate defence.
  26. (2005). Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from
  27. (1986). Asparagine-linked sugar chains of fetuin: occurrence of tetrasialyl triantennary sugar chains containing the Gal beta 1-3GlcNAc sequence.
  28. (2006). Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease.
  29. (2005). Bacteremia among children admitted to a rural hospital in Kenya. The New England
  30. (1990). Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Reviews of Infectious Diseases.
  31. (1958). Bacterial flora of the upper respiratory tract in Paddington families.
  32. (2009). Barrier properties of mucus.
  33. (2007). Beta-D-glucoside utilization by Mycoplasma mycoides subsp. mycoides SC: possible involvement in the control of cytotoxicity towards bovine lung cells.
  34. (1981). Beta-Galactosidase of Streptococcus cremoris.
  35. (1997). Binding of the catabolite repressor protein CcpA to its DNA target is regulated by phosphorylation of its corepressor HPr.
  36. (1987). Biological role of the pneumococcal amidase. Cloning of the lytA gene in Streptococcus pneumoniae.
  37. (1984). Buiding and Breaking of bonds in the cell wall of bacteria- the role for autolysin. Microbial Cell Wall and Autolysins.
  38. (2001). Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention. Clinical Infectious Diseases.
  39. (1990). Capsular polysaccharides as vaccine candidates. Current Topics in Microbiology and Immunology.
  40. (2006). Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.
  41. (2007). Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infection and Immunity.
  42. (2009). Carbon catabolite control of the metabolic network in Bacillus subtilis.
  43. (2008). Carbon catabolite repression in bacteria: many ways to make the most out of nutrients.
  44. (2000). Carbon catabolite repression in Lactobacillus pentosus: analysis of the ccpA region.
  45. (2005). Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae.
  46. (1996). Catabolite repression mediated by the catabolite control protein CcpA in Staphylococcus xylosus.
  47. (2007). CcpA-dependent and -independent control of betagalactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon.
  48. (2004). CD4-Tlymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.
  49. (1999). Cellobiose-6-phosphate hydrolase (CelF) of Escherichia coli: characterization and assignment to the unusual family 4 of glycosylhydrolases.
  50. (2004). Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.
  51. (1997). Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae.
  52. (2009). Characterization of a novel {beta}-galactosidase activity contributing to glycoprotein degradation and virulence
  53. (1976). Characterization of an endoalpha-N-acetyl galactosaminidase from Diplococcus pneumoniae.
  54. (2001). Characterization of selected strains of pneumococcal surface protein A.
  55. (2002). Characterization of the dihydrolipoamide dehydrogenase from Streptococcus pneumoniae and its role in pneumococcal infection.
  56. (1994). Characterization of the group B streptococcal hyaluronate lyase.
  57. (2009). Characterization of the Streptococcus pneumoniae BgaC protein as a novel surface beta-galactosidase with specific hydrolysis activity for the Galbeta1-3GlcNAc moiety of oligosaccharides.
  58. (2007). Childhood pneumonia mortality - a permanent global emergency.
  59. (2000). Cholesterol-binding cytolytic protein toxins.
  60. (1970). Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme.
  61. (1996). Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli.
  62. (1995). Cloning and expression of the beta-Nacetylglucosaminidase gene from Streptococcus pneumoniae. Generation of truncated enzymes with modified aglycon specificity.
  63. (1994). Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infection and Immunity.
  64. Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infection and Immunity.
  65. (2004). Comparative antimicrobial susceptibility of respiratory tract pathogens.
  66. (1992). Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae.
  67. (1999). Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infection and Immunity.
  68. (1997). Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases.
  69. (1996). Competence pheromone, oligopeptide permease, and induction of competence in Streptococcus pneumoniae.
  70. (2000). Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model.
  71. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.
  72. (2001). Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.
  73. (2008). Conjugation Chemistry.
  74. (2006). Construction and evaluation of a chromosomal expression platform (CEP) for ectopic, maltose-driven gene expression in Streptococcus pneumoniae.
  75. (1989). Contribution of autolysin to virulence of Streptococcus pneumoniae.
  76. (1997). Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.
  77. (1997). Control of the shift from homolactic acid to mixed-acid fermentation in Lactococcus lactis: predominant role of the NADH/NAD+ ratio.
  78. (1990). Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods.
  79. (2004). Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
  80. (2006). Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae.
  81. (1996). Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells.
  82. (2002). Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays.
  83. (1971). DNA uptake during genetic transformation and the growing zone of the cell envelope.
  84. (2004). Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H.
  85. (1992). Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microbial Pathogenesis.
  86. (1989). Effect of priming with carrier on response to conjugate vaccine.
  87. (1999). Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrobial Agents and Chemotherapy.
  88. (2006). Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clinical Infectious Diseases.
  89. (1993). Energy transduction in lactic acid bacteria.
  90. (1980). Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.
  91. (1988). Evidence for high affinity binding-protein dependent transport systems in gram-positive bacteria and in Mycoplasma.
  92. (1972). Experiments in Molecular Genetics. 1st ed.
  93. (1998). Expression and purification of Streptococcus pneumoniae hyaluronate lyase from Escherichia coli. Protein Expression and Purification.
  94. (2004). Extracellular virulence factors of Streptococcus pneumoniae.
  95. (1980). Formation of cell wall polymers. Microbial Cell Wall and Membranes.
  96. (2004). From mucins to mucus: toward a more coherent understanding of this essential barrier.
  97. (1967). Further studies on the nasal flora of people of Papua-New Guinea.
  98. (1974). Genetic evidence for the physiological significance of the D-tagatose 6-phosphate pathway of lactose and D-galactose degradation in Staphylococcus aureus.
  99. (2001). Genome of the bacterium Streptococcus pneumoniae strain R6.
  100. (2008). Growth of Streptococcus pneumoniae on human glycoconjugates is dependent upon the sequential activity of bacterial exoglycosidases.
  101. (2000). Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function.
  102. (2006). How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria.
  103. (1948). Hyaluronidase production by pneumococci.
  104. (2005). Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-alpha-N-acetylgalactosaminidase from Bifidobacterium longum.
  105. (2009). Identification of a pneumococcal glycosidase that modifies O-linked glycans.
  106. (2006). Identification of amino acids essential for catalytic activity of pneumococcal neuraminidase A. Research in Microbiology.
  107. (2001). Identification of human endomucin-1 and -2 as membrane-bound Osialoglycoproteins with anti-adhesive activity.
  108. (2004). Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin.
  109. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules.
  110. (1994). Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.
  111. (2010). Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice. Infection and Immunity.
  112. (2005). Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization. Infection and Immunity.
  113. (1990). Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek.
  114. (2006). Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. The Pediatric Infectious Disease
  115. impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.
  116. In vivo binding of complement regulator factor H by Streptococcus pneumoniae.
  117. (2002). In vivo characterization of the psa genes from Streptococcus pneumoniae in multiple models of infection.
  118. (2002). Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
  119. (2001). Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in
  120. (2002). Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infection and Immunity.
  121. (1998). Infant B cell responses to polysaccharide determinants.
  122. (1992). Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clinical Infectious Diseases.
  123. (2003). Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.
  124. (1988). Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae.
  125. (2000). Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
  126. (2004). Involvement of Streptococcus gordonii beta-glucoside metabolism systems in adhesion, biofilm formation, and in vivo gene expression.
  127. (2002). Is the glycolytic flux in Lactococcus lactis primarily controlled by the redox charge? Kinetics of NAD(+) and NADH pools determined in vivo by 13C NMR.
  128. (2002). Isolation and characterization of MUC15, a novel cell membrane-associated mucin.
  129. (2001). Kinetic properties of Streptococcus pneumoniae hyaluronate lyase.
  130. (1974). Lactose and D-galactose metabolism in group N streptococci: presence of enzymes for both the D-galactose 1-phosphate and D-tagatose 6-phosphate pathways.
  131. (1973). Lactose and D-galactose metabolism in Staphylococcus aureus: pathway of D-galactose 6-phosphate degradation.
  132. (1999). Magnitude of the problem of childhood pneumonia.
  133. (1988). Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids.
  134. (1992). Mechanisms of host defense against infection with Streptococcus pneumoniae. Clinical Infectious Diseases.
  135. (1990). Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages.
  136. (1993). Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins.
  137. (1997). Molecular analysis of virulence factors of Streptococcus pneumoniae. Society for Applied Bacteriology symposium series.
  138. (1999). Molecular and cellular biology of pneumococcal infection.
  139. (2007). Molecular EPidemiology and Mechanisms for Antibiotic Resistance in Streptococcus pneumoniae.
  140. (1992). Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.
  141. (1998). MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.
  142. (1992). Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, Nacetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria.
  143. (1991). Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins. The American Review of Respiratory Disease.
  144. (1992). Mucins: structure, function, and role in pulmonary diseases.
  145. (2002). Mucus clearance as a primary innate defense mechanism for mammalian airways.
  146. (1989). Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae. The Southeast Asian
  147. (2005). NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis.
  148. (2000). Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrobial Agents and Chemotherapy.
  149. (1995). Nasal mucociliary clearance in perennial rhinitis.
  150. (1996). Nasopharyngeal carriage of pneumococci in Gambian children and in their families. The Pediatric Infectious Disease
  151. (2004). Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clinical Infectious Diseases.
  152. (2001). Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.
  153. (2000). Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae.
  154. (1986). Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli.
  155. (2000). O-linked chain glycosyltransferases.
  156. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children.
  157. (1970). On the Mechanism of Catabolite Repression.
  158. (2005). Overview on sugar metabolism and its control in Lactococcus lactis - the input from in vivo NMR.
  159. (1991). Pathogenesis and sequelae of respiratory infections.
  160. (1991). Pathogenesis of pneumococcal pneumonia.
  161. (2009). Pathogenesis, treatment, and prevention of pneumococcal pneumonia.
  162. (2006). Pediatric Multicenter Pneumococcal Surveillance Group,
  163. (2004). Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway.
  164. (1997). Phospho-betaglucosidase from Fusobacterium mortiferum: purification, cloning, and inactivation by 6-phosphoglucono-delta-lactone.
  165. (1985). Phosphoenolpyruvate:carbohydrate phosphotransferase system of bacteria.
  166. (1993). Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria.
  167. (1994). Physicochemical analyses of oligosaccharide determinants of glycoproteins.
  168. (1996). Physiology of pyruvate metabolism in Lactococcus lactis.
  169. (1984). Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clinical and Experimental Immunology.
  170. (2003). Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.
  171. (2009). Pneumococcal biofilms.
  172. (1985). Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory.
  173. (2001). Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study.
  174. (2003). Pneumococcal Infection Study Network,
  175. (1975). Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. The American Review of Respiratory Disease.
  176. (2010). Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Molecular Oral Microbiology.
  177. (2001). Pneumococcal nasopharyngeal colonization in young South Indian infants. The Pediatric Infectious Disease
  178. (2006). Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infection and Immunity.
  179. (1992). Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae.
  180. (2008). Pneumococcal Serotype Epidemiology.
  181. (1990). Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
  182. (2004). Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice.
  183. (2001). Pneumococcal virulence factors: structure and function.
  184. (2007). Pneumococcal Virulence Factors.
  185. (2001). Polymorphism of the human muc genes. Frontiers in Bioscience : a Journal and virtual library.
  186. (1963). Preparation of transforming deoxyribonucleic acid by phenol treatment.
  187. (1994). Production of specific glycosidase activities by Streptococcus intermedius strain UNS35 grown in the presence of mucin.
  188. (1996). Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microbial Pathogenesis.
  189. (1995). Protein kinasedependent HPr/CcpA interaction links glycolytic activity to carbon catabolite repression in gram-positive bacteria.
  190. (1995). Protein phosphorylation and regulation of carbon metabolism in gram-negative versus grampositive bacteria. Trends in Biochemical Sciences.
  191. (1997). PspA and PspC: their potential for use as pneumococcal vaccines.
  192. (2006). Purification and properties of beta-galactosidase from Streptococcus thermophilus.
  193. (2009). Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence. Infection and Immunity.
  194. (2003). Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.
  195. (1989). Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
  196. (1997). Regulation of energy source metabolism in streptococci. Society for Applied Bacteriology symposium series.
  197. (2001). Regulation of pyruvate metabolism in Lactococcus lactis depends on the imbalance between catabolism and anabolism.
  198. (1999). Regulation of the alpha-galactosidase activity in Streptococcus pneumoniae: characterization of the raffinose utilization system.
  199. (2001). Regulatory functions of serine-46-phosphorylated HPr in Lactococcus lactis.
  200. (1950). Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro.
  201. (2006). Respiratory tract mucin genes and mucin glycoproteins in health and disease.
  202. (2001). Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infection and Immunity.
  203. (2000). Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae.
  204. (2002). Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.
  205. (2002). Role of RegM, a homologue of the catabolite repressor protein CcpA, in the virulence of Streptococcus pneumoniae.
  206. (2002). Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infection and Immunity.
  207. (1989). Sequence analysis and expression in Escherichia coli of the hyaluronidase gene of Streptococcus pyogenes bacteriophage H4489A. Infection and Immunity.
  208. (1996). Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae.
  209. (1999). Sequential deglycosylation and utilization of the N-linked, complex-type glycans of human alpha1-acid glycoprotein mediates growth of Streptococcus oralis.
  210. (2006). Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease
  211. (2006). Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
  212. (1995). Six newly recognized types of Streptococcus pneumoniae.
  213. (1981). Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Reviews of Infectious Diseases.
  214. (1986). Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symposia on Quantitative Biology.
  215. (1997). SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component.
  216. (1995). Streptococcus pneumoniae anchor to activated human cells by the receptor for plateletactivating factor.
  217. (2004). Streptococcus pneumoniae colonisation: the key to pneumococcal disease. The Lancet Infectious Diseases.
  218. (2004). Streptococcus pneumoniae: epidemiology and patterns of resistance.
  219. (2007). Streptococcus pneumoniae: From colonization and Infection towards prevention strategies.
  220. (1992). Structural analysis and biological significance of the cell wall lytic enzymes of Streptococcus pneumoniae and its bacteriophage.
  221. (2000). Structural basis of pore formation by cholesterol-binding toxins.
  222. (1992). Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis.
  223. (2008). Structure and function of the polymeric mucins in airways mucus.
  224. (1995). Structure of the cell wall anchor of surface proteins in Staphylococcus aureus.
  225. (1933). Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasivness.
  226. (1991). Surface layers of bacteria.
  227. (1999). Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.
  228. (2000). Synthesis and posttranslational regulation of pyruvate formate-lyase in Lactococcus lactis.
  229. (1998). Systematic identification of essential genes by in vitro mariner mutagenesis.
  230. (2004). Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.
  231. (2008). The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae.
  232. (1990). The ami locus of the gram-positive bacterium Streptococcus pneumoniae is similar to binding protein-dependent transport operons of gram-negative bacteria.
  233. (1988). The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanasereleased oligosaccharides by 500-megahertz 1H NMR spectroscopy.
  234. (1999). The burden of pneumococcal disease: the role of conjugate vaccines.
  235. (2004). The effect of pfl gene knockout on the metabolism for optically pure D-lactate production by Escherichia coli.
  236. (1938). The estimation of the bactericidal power of the blood.
  237. (2001). The family of thiol-activated, cholesterol-binding cytolysins.
  238. (2003). The function of hydrophobic residues in the catalytic cleft of Streptococcus pneumoniae hyaluronate lyase. Kinetic characterization of mutant enzyme forms.
  239. (2008). The global epidemiology of childhood pneumonia 20 years on.
  240. (1996). The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. The FASEB Journal: official publication of the Federation of American Societies for Experimental Biology.
  241. (2006). The mechanism of pore formation by bacterial toxins.
  242. (2008). The mechanisms of carbon catabolite repression in bacteria.
  243. (1915). The occurrence of carriers of disease-producing types of pneumococcus.
  244. (2000). The pneumococcal conjugate vaccine arrives: a big win for kids. The Pediatric Infectious Disease
  245. (2000). The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells.
  246. (1984). The preparation of heparan sulfate from the mitral valve of the human heart.
  247. (1940). The relationship of immediate family contact to the transmission of type-specific pneumococci.
  248. (1981). The role of complement in the host's defense against Streptococcus pneumoniae. Reviews of Infectious Diseases.
  249. (1995). The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus.
  250. (2008). The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.
  251. (2000). The Streptococcus pneumoniae beta-galactosidase is a surface protein.
  252. (2003). The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice.
  253. (2007). The two-component regulatory system TCS08 is involved in cellobiose metabolism of Streptococcus pneumoniae R6.
  254. (2004). Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.
  255. (1999). Transformation of a type 4 encapsulated strain of Streptococcus pneumoniae.
  256. (1972). Type distribution and antibiotic sensitivity of pneumococci from carriers in Kiriwina, Trobriand islands (New Guinea).
  257. (1988). Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci.
  258. (2002). Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type.
  259. (1990). Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.
  260. (2006). Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infection and Immunity.
  261. (2006). Versatility of pneumococcal surface proteins.
  262. (2002). Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress.
  263. (1991). Virulence, immunity, and vaccine related to Streptococcus pneumoniae.
  264. (2003). Where and why are 10 million children dying every year?

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.